Alternatively: GOAT FLAP with the second 'A' for Anti - diuretic hormone/ Vasopressin
❐⇐Note:there also melanocyte secreting hormone and lipotropin, but they are not well understood.
#الصيدلاني_شوقي_الحشيبـري
♨️👈علق بكلمة " تـــــم " ليصلك كــــل جديد من منشوراتنا •┈┈•◈◉❒ 🅢🅗 ❒◉◈•┈┈• {🍥}➪ تــابعـــو قنـــاتنــا علــى التيــليــجــرام: قنــــــاه All medicine in yemen https://www.tg-me.com/alhoshebry774876531
Alternatively: GOAT FLAP with the second 'A' for Anti - diuretic hormone/ Vasopressin
❐⇐Note:there also melanocyte secreting hormone and lipotropin, but they are not well understood.
#الصيدلاني_شوقي_الحشيبـري
♨️👈علق بكلمة " تـــــم " ليصلك كــــل جديد من منشوراتنا •┈┈•◈◉❒ 🅢🅗 ❒◉◈•┈┈• {🍥}➪ تــابعـــو قنـــاتنــا علــى التيــليــجــرام: قنــــــاه All medicine in yemen https://www.tg-me.com/alhoshebry774876531
Spiking bond yields driving sharp losses in tech stocks
A spike in interest rates since the start of the year has accelerated a rotation out of high-growth technology stocks and into value stocks poised to benefit from a reopening of the economy. The Nasdaq has fallen more than 10% over the past month as the Dow has soared to record highs, with a spike in the 10-year US Treasury yield acting as the main catalyst. It recently surged to a cycle high of more than 1.60% after starting the year below 1%. But according to Jim Paulsen, the Leuthold Group's chief investment strategist, rising interest rates do not represent a long-term threat to the stock market. Paulsen expects the 10-year yield to cross 2% by the end of the year.
A spike in interest rates and its impact on the stock market depends on the economic backdrop, according to Paulsen. Rising interest rates amid a strengthening economy "may prove no challenge at all for stocks," Paulsen said.
At a time when the Indian stock market is peaking and has rallied immensely compared to global markets, there are companies that have not performed in the last 10 years. These are definitely a minor portion of the market considering there are hundreds of stocks that have turned multibagger since 2020. What went wrong with these stocks? Reasons vary from corporate governance, sectoral weakness, company specific and so on. But the more important question is, are these stocks worth buying?
